Chairman | Ebino centro Clinic | Research Excellence Award
Dr. Nagai, Kenjiro is a clinician–researcher affiliated with Ebino Sentoro Clinic, Japan, specializing in infectious diseases, immunotherapy, and respiratory disorders, particularly virus-associated pulmonary complications. He has authored 19 Scopus-indexed publications and received over 565 citations, achieving an h-index of 11, which reflects sustained academic influence and research quality. With 41 co-authors, he maintains active multidisciplinary collaborations that enhance translational and clinical research outcomes. Among his notable contributions is an open-access case report published in BMJ Case Reports examining amplified natural killer cell therapy for HTLV-1–associated bronchiolitis and alveolar abnormalities. His work emphasizes innovative, evidence-based, and patient-centered therapeutic strategies. Through clinical scholarship, collaborative engagement, and translational application of immunotherapeutic approaches, Dr. Nagai contributes meaningfully to improving treatment outcomes and advancing global understanding of complex infectious and immune-mediated diseases.
Citation Metrics (Scopus)
View Scopus Profile
Featured Publication
